The Stakeholder Advocacy Division of the Academy of Radiology Research

Coalition for Imaging and Bioengineering Research

www.imagingcoalition.org

July 2011
Advocate Staff
Rene L. Cruea, MPA
President

Director of NIH Headlines CIBRs Imaging Showcase on Capitol Hill

Rene Cruea, CIBR President Washington, DC On May 19th, the Coalition for Imaging and Bioengineering Research (CIBR) sponsored the second annual imaging technology showcase in the Rayburn Foyer entitled: The Impact of Imaging Research, Technology & Patient Care. The event provided an opportunity for attendees to visit nine unique technology display areas, each represented by a patient advocate, academic researcher and manufacturer. With displays focusing on areas such as cutting-edge computed tomography (CT), novel magnetic resonance imaging (MRI), or decision support software (which assists radiologists in administering the right scan), congressional guests were able to gain a deeper understanding of how imaging research is changing the detection, diagnosis and treatment of disease.

Michael Kalutkiewicz Roxanne Yaghoubi

Vice President of Government Affairs Policy and Programs Manager

Charisse Balangawan Angela Quick Sadaf Samay

Assistant Editors

..

Steering Committee
William G. Bradley, Jr, MD, PhD Chair, Department of Radiology University of California San Diego Chairman Steven Seltzer, MD Chair, Department of Radiology Brigham and Womens Hospital ARR President Sholom Ackelsberg General Manager, Academic Research Portfolio GE Healthcare Pat A. Basu, MD, MBA Faculty (On Leave) Stanford University Jim Beckett Vice President, Clinical Research Philips Healthcare R. Nick Bryan, MD, PhD Chair, Department of Radiology University of Pennsylvania Health System N. Reed Dunnick, MD Chair, Department of Radiology University of Michigan Medical Center Daniel Garen, JD, LLM Vice President, Healthcare Policy and Clinical Affairs Siemens Healthcare Steven Haberlein Vice President, Sales FUJIFILM Medical Systems USA, Inc. James Jorkasky Executive Director National Alliance for Eye and Vision Research Q.Y. Ma, PhD President and CEO TIME MEDICAL Systems, Inc. Richard Mather, PhD Senior Manager, Clinical Programs Toshiba Medical Research Institute Oran Muduroglu CEO Medicalis Corporation Martha Nolan, JD Vice President, Public Policy Society for Women's Health Research Lenny Reznik Director, Enterprise Imaging and Information Agfa HealthCare Corporation Sheila Ross Special Counsel Lung Cancer Alliance Paul Tuma Regional Vice President Nuance Communications, Inc. Nuance Healthcare Division

Francis Collins, MD, PhD

In addition to the technologies being presented, the event was highlighted by a number of special guests who have been champions, advocates and leaders in the field of research. Academy of Radiology Research Vice President, Richard Ehman, MD, from the Mayo Clinic introduced Senator Amy Klobuchar (D-MN), a long-time champion for research. Sen. Klobuchar spoke about the need for America to recommit to an innovation economy led by the National Institutes of Health (NIH). Continued on page 2

Academy Presidents Welcome

Steven Seltzer, MD
Welcome to this edition of the CIBR Newsletter! The past few months have been very busy ones for CIBR. Members of CIBR including several Chairs of leading academic radiology departments spent several days in Washington, DC this Spring, visiting with seven Chair of Radiology, National Institutes of Health Brigham & Womens (NIH) Directors, spending time Hospital with our legislators on Capitol Hill and participating in educational Congressional briefings which highlighted the power and potential of federally funded research in imaging and bioengineering to improve patient care. During our time on Capitol Hill we briefed members of Congress and their staffs about the importance of maintaining at a minimum the current level of support for NIH in general and imaging research in particular. We reminded them about some of the tremendous research news of the past year, including the dramatic results of the National Lung Screening Trial, which showed a 20 percent reduction in deaths from lung cancer through the use of low-dose CT. We also shared information

about federally funded imaging research going on in their districts, particularly efforts to improve patient care, lower costs and manage radiation exposure. A highlight of our visit was a medical technology expo held in the foyer of the Rayburn House Office building. Exhibits displayed new imaging technologies and highlighted collaboration between patient advocacy groups, industry, and academia. Senator Amy Klobuchar (D-MN) and NIH Director Francis Collins both made gracious and positive remarks about the value of biomedical imaging research. As CIBR continues to implement initiatives that educate our audience, we will be monitoring the federal budget debate and doing our best to rally support for research funding. We have been working with Director Collins office to express our opinions about a role for imaging in the proposed new Institute for NIH, the National Center for Advancing Translational Sciences (NCATS). In addition, we have been in contact with Dr. Harold Varmus and the leadership of the National Cancer Institute (NCI) to ensure a good outcome for the American College of Radiology Imaging Network (ACRIN), one of the NCIs ten cooperative clinical trials groups. Thank you as always for your help and support for CIBR.

Coalition for Imaging and Bioengineering Research

1029 Vermont Avenue, NW, Suite 505 Washington, DC 20005 imagingcoalition.org

www.imagingcoalition.org
Welcome to our Coalition newsletter. It is important to remember that a coalition is an alliance among groups that join forces for a common interest. Coordination among similar groups such as those within the imaging community is a critical ingredient for achieving change through education and advocacy on a broad scale. While the more than 140 members of CIBR have differing advocacy agendas, there are clearly areas of overlap as we come together in support of imaging research.
Rene Cruea, collaborative initiatives. The value of a diverse and strong Coalition has never President, CIBR

m Acade

In this newsletter we have highlighted for you some of our most effective

been more important than it is today.

The mission of CIBR is to create and maintain a supportive environment for imaging research. Awareness of the direct impact and value imaging brings to patient care assists in our efforts to garner support for consistent federal investment in imaging research. Thank you for your continued support of CIBR as a patient group, academic department, society, industry partner or Congressional staffer. Please feel free to contact us anytime with questions about our activities or membership.

nts y Preside 1 p. Welcome gy Technolo R Medical CIB p. 1 & 2 Showcase onp. 3 C Recepti ARRA t on Lu ng Statemen IASLC p. 4 reening Cancer Sc 5-6 . otligh tp PAG Sp ngp. 7 ers Briefi im Alzhe te p. 8 a ative Upd Legisl p. 9 ry News Indust & 11 istp. 10 ership L 12 Memb ationp. er Appreci Memb

ue In This Iss

Continued from page 1 Mr. Arthur Cassano, a patient advocate who survived a brain aneurysm due to a timely and advanced imaging diagnosis, then provided personal testimony about his own survival thanks to the radiologists at the University of Virginia. Mr. Cassano passionately called on policymakers to raise the level of support for life sciences research, and to consider his story as an example of how research is literally saving lives and reducing long-term care.

is being translated into actual treatments and cures. The President of the Academy of Radiology Research, Steven Seltzer, MD, of Brigham and Womens Hospital in Boston, closed by applauding Dr. Collinss vision and leadership, and promised that the imaging community is ready and willing to help bring faster cures to patients.

Overall, approximately 300 people attended the medical showcase. Attendees included a The keynote speaker for the event was the Director of the Nation- mix of Senators, Representatives, congresal Institutes of Health, Dr. Francis Collins, MD, PhD. Dr. Collins sional staffers, patient advocates, industry, highlighted some of the recent accomplishments of researchers, academic leadership and NIH staffers. such as the success of the National Lung Screening Trial.
Senator Amy Klobuchar (D-MN)

The Director also described his vision for a proposed new center at NIH, the National Center for Advancing Translation Sciences (NCATS), and delineated how advanced imaging techniques can expedite promising new treatments for patients. He concluded by encouraging Attendees gather in the congressional support for reRayburn Foyer search so that it remains a national priority, particularly at a time when so much basic science

Francis Collins, MD, PhD visits with Q.Y. Ma, PhD, CEO of TIME MEDICAL Systems, Inc.

Mr. Cassano passionately called on policymakers to raise the level of support for life sciences research, and to consider his story as an example of how research is literally saving lives and reducing long-term care.

The CIBR annual imaging showcase is an opportunity for our audience to hear collectively from all members of the imaging community in one setting, and to develop a more complete vision of the impact imaging technology has on patient care. Rene Cruea, MPA, President, CIBR
July 2011 Page 2

www.imagingcoalition.org

On Capitol Hill, Top U.S. Academic Radiology Departments Convene to Showcase CuttingEdge Academic Imaging Research
Rene Cruea, MPA, President On May 18, 2011, the Academy of Radiology Researchs Academic Council sponsored its second annual congressional reception focusing on the latest advancements in imaging research. Chairs and representatives from leading academic radiology departments presented posters which displayed a snapshot of their institutions ongoing imaging research projects. Members of Congress, staff and patient advocates were able to meet some of their States top academic researchers, and staff and Members were encouraged to talk with poster-presenters about their research and actually participate in the process by which science is vetted and disseminated.

The popular event filled the Gold Room of the Rayburn House Office Building, with an attendance of 185 Congressional staffers, patient advocates, NIH staffers and industry representatives. The overall attendance was up 55% from 2010. More than 20 Academic Radiology Departments, including twelve Department Chairs, provided detailed research posters depicting cutting-edge imaging research at their institution. Guests enjoyed wine, hors doeuvres and an ice cream bar as they networked and read the research posters. For many Congressional members and staff, it was their first opportunity to meet Chairs from their home state or districts institutions. Academic research Chairs and patient advocates were easily identified by their large lanyard name tags that clearly stated their name, state and University or patient advocacy group affiliation. Guest speakers included Martha Nolan, Vice President for Public Policy of the Society for Womens Health Research, James Jorkasky, Executive Director of the National Alliance for Eye and Vision Research and Special Counsel Sheila Ross from the Lung Cancer Alliance, who is also a lung cancer survivor. We were honored to hear from these three CIBR Steering Committee members as they articulated to a full James Jorkasky (NAEVR) & room why imaging research was imMartha Nolan, JD (SWHR) portant to their patient constituency. This reception was a lead-in to the CIBR medical technology reception and showcase on May 19 th. Over the course of three days, Academy, Academic Council and CIBR leadership met with NIH leadership at seven Institutes, Academic Chairs met with their elected Representatives and the CIBR Steering Committee held a spring meeting to discuss and plan further advocacy initiatives.

CIBR and Academy Leadership: William Bradley Jr. MD, PhD (UCSD), Jonathan Lewin, MD (Hopkins), Carolyn Meltzer, MD (Emory), Rene Cruea (CIBR), Steven Seltzer, MD (Brigham & Womens), Richard Ehman, MD (Mayo), Mike Kalutkiewicz (CIBR)

July 2011

Page 3

www.imagingcoalition.org

LCA Praises International Statement on CT Screening, While NIH Lung Cancer Trial Shows 20 percent Reduction in Deaths due to CT

By Michael J. Kalutkiewicz Vice President of Government Affairs On nearly the same day that the Lung Cancer Alliance (LCA) praised a position paper on computed tomography (CT) screening issued by the International Association for the Study of Lung Cancer (IASLC), the National Institutes of Health (NIH) issued a press release describing a 20 percent reduction in deaths from lung cancer through The question is the use of low-dose CT. CIBR is proud to work with the LCA, one of its patient advocacy groups and Steering Committee members, to advocate for the use of biomedical imaging research to assist lung cancer patients. no longer does The IASLC position paper noted that CT screening is the first test of any type to demonstrate significant reductions in lung cancer mortality through early detection and called for international cooperation and national screening programs around the world to refine the process. Laurie Fenton-Ambrose, LCA President & CEO said the IASLC's consensus statement signals a new beginning. "The question is no longer does CT screening work, but how do we bring this benefit to those at high risk as safely, efficiently and equitably as possible, and IASLC's call for international cooperation on reaching that goal as expeditiously as possible is a very positive and important development," she said. The paper from the IASLC was released at nearly the same time as the primary research data from the National Lung Screening Trial, which was funded by the NIH, was also published in the New England Journal of Medicine. Through the NLST, scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical CT versus those screened by chest X-ray. We are thrilled that the lung cancer detection paradigm is changing for the better because of imaging, said CIBR President Rene Cruea. We hope that LCA is successful in its outreach as it strives to reduce mortality associated with lung cancer. The imaging community, through CIBR, will continue to collaborate with LCA, a valuable partner, to raise public awareness with regards to the value, contribution and patient impact of CT. Fenton-Ambrose praised the IASLC's call for better integration of public health messages for both tobacco control and lung cancer early detection. "The majority of new lung cancer cases are former smokers who were not being warned that they could still be at risk years, or even decades, after quitting," she said. LCA recently opened the first publicly available website designed to help people answer questions about CT screening, such as "Am I at risk?" and "Where should I go?" The website can be accessed at www.screenforlungcancer.org.

CT screening work, but how do we bring this benefit to those at high risk as safely, efficiently and equitably as possible, and IASLC's call for international cooperation on reaching that goal as expeditiously as possible is a very positive and important development."
-Laurie FentonAmbrose

Lung Cancer Alliance (www.lungcanceralliance.org) is the only national non-profit organization dedicated to providing support and advocacy for those living with or at risk for lung cancer. LCA is committed to reversing decades of stigma and neglect by empowering those with or at risk for lung cancer, elevating awareness and changing health policy.

July 2011

Page 4

www.imagingcoalition.org

Representatives from Are You Dense Advocacy, Inc. and Are You Dense, Inc. were delighted to participate in the 2nd annual CIBR Medical Showcase. JoAnn Pushkin, Director of Government Relations for Are You Dense Advocacy, Inc. and Dr. Nancy Cappello, President and Founder of Are You Dense, Inc., found the Showcases spotlight on new technology, research initiatives and advocacy associations a valuable and productive coalition of imaging enthusiasts to align with.

to mandate insurance coverage for whole breast ultrasound screening as an adjuvant tool to mammography for women with dense breast tissue. In 2009, Connecticut became the first state to mandate the communication of breast density information to the patient through the mammography report.

Are You Dense Advocacy, Inc. grew out of the grassroots efforts of D.E.N.S.E. (Density Education National Survivors Effort). It began as a group of women each advocating for Are You Dense, Inc. was founded in 2008 by Dr. Nancy Mandatory Breast Density Disclosure laws within their own Cappello after her advanced stage breast cancer diagnosis states. Connecticuts groundbreaking law became the rallying following a decade of normal mammograms. It was the first point for this group of breast cancer survivors - all of whom time that she was informed she had dense breasts, and that received a later stage diagnosis than necessary because they density masked the ability of the mammogram to find her were not told about their own breast density, nor that density cancer. The goals of Are You Dense, Inc. are to inform the interfered with the effectiveness of their mammograms. In public about the risks of dense breast tissue, and to educate addition to active grassroots efforts in many states, there are the public about the limitations of mammography to detect currently two states with bills pending, California and Texas cancer in women with dense breast tissue. Through the advocacy efforts of Dr. Cappello, Connecticut became the first state Continued on page 6

ZERO the Project to End Prostate Cancer works with the Coalition for Imaging and Bioengineering Research (CIBR) to help advance imaging research for prostate cancer. Advances in imaging are needed to improve doctors' ability to diagnose and determine appropriate treatment options for their patients. CIBR plays an important role by keeping its partners up to date on important advances in imaging research and providing networking opportunities with other members in the imaging community.

patients, education to those at risk, and free prostate cancer screenings throughout the country. Through programs such as the Drive Against Prostate Cancer, the Great Prostate Cancer Challenge, and the Summit to End Prostate Cancer, ZERO is working toward our goal of ending prostate cancer.

The Drive Against Prostate Cancer is the only nationwide mobile prostate cancer screening program. The program has tested more than 110,000 men since 2002, saving more than 7,000 lives. To celebrate over a decade of saving lives, a chariZERO is committed to not only reducing prostate cancer or table foundation has recently challenged ZERO to double the alleviating the pain from the disease, but also to ending it. number of men tested through the Drive Against Prostate ZERO seeks a future where all men who have been diagnosed Cancer. Contributions from individuals and companies to the with prostate cancer will be cured or be able to manage their Double the Drive Matching Campaign will be matched dollar illness with good quality of life. ZERO also works to provide for dollar, up to $1 million, and will be used to expand outmen with the support that they need to minimize physical reach by building a new testing vehicle and doubling the and emotional suffering and cope effectively throughout their number of testing days. cancer journey. Continued on page 6 ZERO provides comprehensive treatment information to

July 2011

Page 5

www.imagingcoalition.org

Are You Dense, Inc.Continued from page 5 have Inform laws on their books, and a federal bill is in the draft phase. The CIBR showcase was the perfect venue to focus our efforts on supporting Density/Inform federal legislation. Are You Dense Advocacy (AYDA) fully supports a patients knowledge and access to the right screening so that an early stage diagnosis is attainable. AYDAs organizational objective is equal access to early detection for the 40% of women with dense breasts. Our mission aligns with the mission of supporting imaging researchers and their quest for earlier diagnoses, less painful and less invasive procedures, improvement in patient care, and cost savings. Finally, it was of particular value to collaborate with other advocacy organizations and professionals in attendance. The Rayburn Foyer was the perfect location for a mix of technology, advocacy and policy discussions. The display and table mix of different disciplines and areas of expertise meant traffic was constant and steady. We look forward to attending next year.

The CIBR showcase was the perfect venue to focus our efforts on supporting Density/ Inform federal legislation.
-Are You Dense, Inc.

ZERO Cancercontinued from page 5

The premier men's health race and event series in America The Great Prostate Cancer Challenge was created by ZERO to bring together athletes, cancer survivors, physicians, caretakers, family members, and friends in the fight against prostate cancer. In 2011, ZERO is hosting run/walk events in 27 cities nationwide with the mission of raising awareness and funds for research and screening. The Summit to End Prostate Cancer is an annual conference focused on legislative and policy issues that impede research and access to care. This years Summit will take place on September 20 and 21 in Washington, D.C. In addition to informational sessions, ZERO staff will provide training in grassroots advocacy, the legislative process, fundraising and communications. ZERO works directly with the federal government and in concert with various coalitions to increase critical research funding, protect patients and their families from harmful policy changes and educate Members of Congress and other decision makers about prostate cancer and the need for early detection. Since 1996, the organization has worked to increase federal research dollars for prostate cancer from $85 million to nearly $500 million. ZERO is leading the fight to end prostate cancer a disease that affects one in six men by promoting greater awareness for early detection and leveraging public resources for life-saving research and new treatments for those with the disease.

Photos from our Medical Technology Showcase!

If you are a Patient Advocate member of CIBR and would like to be featured in the PAG spotlight, please contact Roxanne Yaghoubi at Roxanne@imagingcoalition.org
July 2011 Page 6

www.imagingcoalition.org

CIBR Sponsors Briefings on Alzheimers Research, Imaging Advances

By Roxanne Yaghoubi & Charisse Balangawan On June 22, 2011, the Coalition for Imaging and Bioengineering Research (CIBR) co-hosted two congressional briefings on advances in imaging technology and Alzheimers disease research. Held on both the House and Senate sides of the Capitol, these briefings were cosponsored by the Alliance for Aging Research, the Alzheimers Foundation of America, the Cure Alzheimers Fund, and USAgainstAlzheimers, as well as Senator Warner (D-VA) and Congressman Smith (R-NJ). These types of collaborations play an important role in CIBRs education and advocacy efforts by giving Members of Congress and congressional staffers the opportunity to learn more about the research that is supported by the NIH. The presentations focused on the progress that researchers have made towards using biomedical imaging to diagnose and someday, potentially treat Alzheimers disease. The incidence and associated costs of Alzheimers disease has been on a steady incline due to the rise in the aging population. According to Daniel Perry, President and CEO of the Alliance for Aging Research, in the next 18 years 10,000 adults a day will turn 65 years old. As a result of this Silver Tsunami, Alzheimers research now needs more attention than ever before.

Congressman Chris Smith (R-NJ)

Richard Hodes, MD, the Director of the National Institute on Aging (NIA), emphasized the importance of using imaging to detect early brain changes and track the effectiveness of treatment. Neil Buckholtz, PhD, the Chief of the Dementias of Aging Branch of the Division of Neuroscience at the NIA, followed by showing part of a documentary entitled The Forgetting: A Portrait of Alzheimers. This video depicts the work of researchers from the University of Pittsburgh and Massachusetts General Hospital on Pittsburgh Compound B - a radioactive compound that, when coupled with positron emission tomography (PET) scans, allows researchers to see the location and distribution of the beta amyloid plaque deposits that are associated with Alzheimers.
Dr. Richard Hodes

Following the video, Srinivasan Mukundan, MD, PhD, the Section Chief of Neuroradiology at Brigham and Womens Hospital, discussed the importance of using imaging to help families of Alzheimers disease patients make better decisions about treatment options. Since symptoms of Alzheimers can mimic other diseases, Dr. Mukundan also discussed the importance, particularly in a large hospital, of differentiating Alzheimers patients from other patients with less severe forms of mild cognitive impairment. In addition, during the briefing in the House of Representatives, Congressman Dr. Srinivasan Mukandan Smith spoke about the efforts of the bipartisan Congressional Task Force on Alzheimers disease. The briefings concluded with a presentation by Sue Peschin from the Alzheimers Foundation of America, who highlighted the need for increased funding for the NIA so that it can continue to support this important research. CIBR was pleased to help facilitate this series of briefings and to highlight the hope that imaging research is giving to Alzheimers patients and their families. In the upcoming months, CIBR plans to hold similar presentations on other topics of interest to its membership. If you would like to work with CIBR on this initiative, please contact Roxanne Yaghoubi (roxanne@imagingcoalition.org).

Dr. Richard Hodes (NIA), Sue Peschin (Alzheimers Foundation of America), Dan Perry (Alliance for Aging Research), Dr. Neil Buckholtz (NIA), Dr. Srinivasan Mukandan (Brigham & Womens) , Rene Cruea (CIBR)

July 2011

Page 7

www.imagingcoalition.org

Legislative Update
By Michael J. Kalutkiewicz Vice President of Government Affairs Washington is all about the big picture these days. The discussion surrounding deficit reduction is characterized by slogans about national priorities and ensuring that the country is headed in the right direction. Some leaders want trillions in spending cuts. With such paradigm-changing dialogue, advocates for federal public health initiatives rightly wonder if their programs will continue to exist in their current form (or at all) under the new fiscal path Michael Kalutkiewicz, forward. VP, Government Despite the doom and gloom of budget cuts, a number of people in Washington are saying the right things when it comes to federal investment in health research. 117 Representatives recently signed a letter that circulated among the House calling for at least $32b in funding for the National Institutes of Health (NIH) approximately a 2 percent increase. In the Senate, 41 Senators signed on to a letter that described NIH as our best hope for treating or curing debilitating disease, and said that Congress must sustain its commitment to research. But in reality, the number of champions in each chamber falls well short of the votes needed to ensure that the budget for finding cures does not receive its second cut in as many years.
Affairs

invest in education, infrastructure, and high-value research and development to help our economy grow, keep us globally competitive, and make it easier for businesses to create jobs. Federal Reserve Chairman Ben Bernanke also noted last month that federal investment in research is a building block for economic growth. So while the overall budget debate in the U.S. may seem to imply a hammer will be taken to the discretionary portion of the budget, it appears that its more likely that the tool will be a scalpel. Many on the right still note that the private sector is still not able to increase research and development budgets, and that the role of the federal government in this area has perhaps never been more important. But will these same Members of Congress eventually reemerge as the public champions they have been in the past?

Not necessarily. The last election brought forth a large contingent of extremely fiscally conservative members, and it is likely their ranks will continue to grow in 2012. One Republican Congressman on the House The anticipation of budget reductions is already taking its toll on Appropriations Committee recently said that he is currently the funding decisions of a number of Institutes at the NIH. fighting off a primary opponent Despite their scientific merit, the prospect of declining budgets can make it very difficult for NIH Directors to invest in multi-year that is to the right of him. Having been a strong supporter projects particularly those with costly imaging components. of the NIH for years, the member This is discouraging for advocates of diseases that are on the is characteristic of many elected verge of cures, but need clinical validation for therapeutics or novel treatment modalities. An Institutes appetite for investing officials on both sides of the aisle: their championship for disease research has not waned, in a five-year, multi-site clinical study suddenly wanes as the program directors brace for a 10 to 15 percent cut in purchasing but in the current political environment, their public support for funding programs is tepid. Many members may not be signing power in the fourth and fifth years of the award. public letters in support of NIH, but they will likely still consider it a priority program when it comes time to vote on spending In a national dialogue characterized by spending cuts, public health advocates have been told by traditional supporters on the legislation. Hill and within the Administration to become fiscal policy So while the political environment seems hopeless at times, and experts, in order to explain how public health programs can congressional support for disease research seems uninspiring, stimulate the economy and provide a return on the taxpayers we in the advocacy community must stay active. We must contininvestment. Advocates have pointed to the Presidents recent bipartisan Deficit Reduction Commission which stated, we must ue to be an echo chamber for the patients we represent and the economists that tout the ability of research to move this country forward economically. The fight over spending will likely become 117 Representatives* recently signed a letter increasingly partisan and the dialogue may break down. But CIBR will be working with the larger patient advocacy communithat circulated among the House calling for ty to ensure that through all the dialogue, finding cures and adat least $32b in funding for the National vancing science will be a national priority.

In the Senate, 41 Senators* signed on to a letter that described NIH as our best hope for treating or curing debilitating disease, and said that Congress must sustain its commitment to research.

Institutes of Health approximately a 2% increase.

July 2011

* To find out if your Member of Congress signed the letter in support of NIH, please e-mail Michael@imagingcoalition.org.
Page 8

www.imagingcoalition.org

CIBRs industry partners are all working on their own initiatives regarding biomedical imaging research. Check out these links to learn more!
Visualize the EMR with Agfa HealthCare and IMPAX Data Center, a purpose-built and standards-based Medical Imaging Repository for enterprise and regional data consolidation, vendor-neutral archiving (VNA), and information sharing. IMPAX Data Center enables you to capture, store, exchange, and access medical images, reports, and related information for integration into the patient Electronic Medical Record (EMR). For more information, please visit: http://www.agfahealthcare.com/usa/en/main/ products_services/data_centers/data_centers/impax_data_center.jsp Fujifilms new newsletter, Perspectives, discusses dose management and some of Fujifilms latest technologies. Perspectives includes insights from experienced leaders in the medical imaging industry, product information, as well as service updates. All from FUJIFILM Medical Systems U.S.A. For more information, visit http://perspectives.fujimed.com GE Healthcare recently launched a Patient Safety Organization (PSO) to improve patient safety. The PSO helps members identify root causes of preventable adverse effects, share best practices, change behavior, and deploy practical solutions. For further information, visit www.ge.com/pso Medicalis is the leading developer of radiology workflow solutions for the next generation in productivity, utilization management, and quality. Founded upon deep expertise in evidence-based medicine and the integration of healthcare information systems, the Medicalis Collaborative Workflow Solutions use evidencebased knowledge to enhance productivity and optimize utilization to ensure high-quality, cost-effective care delivery. www.medicalis.com Welcome to the Nuance Healthcare Website. Here you will find detailed information concerning our company and its complete portfolio of industry leading solutions aimed at enhancing the productivity of healthcare providers, reducing overall cost, and most importantly, improving patients clinical outcomes. Additionally, you will find contact information should you have interest in learning more. Thank you. http://www.nuance.com/for-healthcare/index.htm Philips Healthcare presents Imaging 2.0, a new era in radiology science. Just as Web 2.0 redefined the way people connect, share and use the internet, Imaging 2.0 represents a new world of possibilities for radiology. It is about integration and collaboration, and new levels of patient focus that can help clinicians achieve what was unimaginable just a few short years ago. To learn more about Imaging 2.0 and our Philips imaging innovations, visit www.philips.com/imaging2.0 A leader in the integration of imaging and therapy, laboratory diagnostics, and IT, Siemens Healthcare helps optimize patient care from diagnosis to treatment and beyond. Siemens is engaged in current policy, advocating initiatives to help make healthcare faster, better, and more cost-effective. For more information, visit www.usa.siemens.com/reimbursement Time Medical Systems is a start-up company with origins at Columbia University in New York. Their collaborations and R&D efforts with their novel HTS technology are being expanded to other interested academic and clinical partners that support the CIBR mission. For more info on HTS technology and image examples see - www.time-medical.com Toshiba Medical offers healthcare providers the cost-effective, patient-focused medical imaging technology needed to succeed in todays healthcare marketplace. For more information, visit http://medical.toshiba.com
July 2011 Page 9

CIBR Member Organizations

AdMeTech Foundation Agfa HealthCare Corporation Alliance for Aging Research Alliance for Prostate Cancer Prevention Alpha-1 Association Alpha-1 Foundation Alzheimers Foundation of America American Association for Women Radiologists American Association of Physicists in Medicine American Brain Tumor Association American College of Nuclear Medicine American College of Radiology American Institute for Medical and Biological Engineering American Institute of Ultrasound in Medicine American Osteopathic College of Radiology American Pain Foundation American Parkinson Disease Association American Registry of Radiologic Technologists American Roentgen Ray Society American Society of Emergency Radiology American Society of Neuroradiology American Society of Radiologic Technologists Are You Dense, Inc. Are You Dense Advocacy, Inc. Arthritis Foundation Association for Research in Vision and Ophthalmology Association of Community Cancer Centers Association of Educators in Imaging and Radiologic Sciences Association of Program Directors in Radiology Association of University Radiologists Beth Israel Deaconess Medical Center Department of Radiology Biotechnology Industry Organization Blinded Veterans Association Brain Injury Association of America Brigham and Womens Hospital Department of Radiology Cancer Schmancer, Inc. Case Western Reserve University, University Hospitals Health System, Department of Radiology Children With Diabetes Foundation Christopher & Dana Reeve Foundation Colon Cancer Alliance Community Oncology Alliance Cooleys Anemia Foundation COPD Foundation The Daniella Maria Arturi Foundation Duke University School of Medicine Department of Radiology Emory University School of Medicine Department of Radiology and Imaging Sciences Fibroid Relief Fight for Sight Fight Colorectal Cancer First Candle FORCE: Facing Our Risk of Cancer Empowered FUJIFILM Medical Systems USA, Inc. GE Healthcare Georgetown University Medical Center Department of Radiology Hydrocephalus Association Hypertrophic Cardiomyopathy Association International & American Associations for Dental Research International Eye Foundation International Society for Magnetic Resonance in Medicine International WAGR/11p Deletion Syndrome Association Intracranial Hypertension Research Foundation Johns Hopkins Medicine, The Russell H. Morgan Department of Radiology and Radiological Science Juvenile Diabetes Research Foundation Kidney Cancer Association Lighthouse International Lung Cancer Alliance Lung Cancer Circle of Hope MaleCare Mallinckrodt Institute of Radiology, Washington University In St. Louis Massachusetts General Hospital Department of Radiology Mayo Clinic, Department of Radiology Medical College of Wisconsin, Milwaukee WI Department of Radiology Medicalis Corporation Memorial Sloan-Kettering Cancer Center Department of Radiology Mens Health Network Mental Health America Mount Sinai School of Medicine Department of Radiology National Alliance for Eye and Vision Research National Cervical Cancer Coalition National Lung Cancer Partnership National Patient Advocate Foundation

CIBR Member Organizations

National Spinal Cord Injury Association New York University Langone Medical Center Department of Radiology Northwestern University, Feinberg School of Medicine, Department of Radiology Nuance Communications, Inc., Nuance Healthcare Division Parkinsons Action Network Philips Healthcare Prevent Cancer Foundation Prostate Cancer International Prostate Health Education Network Pulmonary Fibrosis Foundation Radiological Society of North America RSNA Research and Education Foundation Siemens Healthcare Society for Imaging Informatics in Medicine Society for Pediatric Radiology Society for Womens Health Research Society of Chairs of Academic Radiology Departments Society of Computed Body Tomography and Magnetic Resonance Society of Interventional Radiology SNM (formerly Society of Nuclear Medicine) Society of Radiologists in Ultrasound Society of Skeletal Radiology Society of Thoracic Radiology Society of Uroradiology Susan G. Komen for the Cure Taking Control of your Diabetes TIME MEDICAL Systems, Inc. Toshiba Medical Research Institute Tuberous Sclerosis Alliance University of California, Irvine Medical Center Department of Radiological Sciences University of California, Los Angeles Department of Radiological Sciences University of California, San Diego School of Medicine Department of Radiology University of California, San Francisco Department of Radiology & Biomedical Imaging University of Kentucky Chandler Medical Center Department of Radiology University of Louisville, Department of Radiology University of Michigan, Department of Radiology University of Minnesota Department of Diagnostic Radiology University of North Carolina at Chapel Hill School of Medicine, Department of Radiology University of Pennsylvania, Department of Radiology University of Pittsburgh Medical Center Department of Radiology University of Texas Medical School at Houston Dept. of Diagnostic & Interventional Imaging University of Utah, Department of Radiology University of Washington, Department of Radiology University of Wisconsin-Madison Department of Radiology Us TOO International Von HippelLindau Disease Family Alliance Voices Against Brain Cancer Yale University School of Medicine Department of Diagnostic Radiology ZEROThe Project to End Prostate Cancer

CIBR Welcomes New Members!

To join CIBR, please contact Mike Kalutkiewicz at Michael@imagingcoalition.org

Agfa HealthCare Corporation Alliance for Aging Research Alzheimers Foundation of America Are You Dense, Inc. Are You Dense Advocacy, Inc. Brain Aneurysm Foundation Brigham and Womens Hospital Colon Cancer Alliance Emory University School of Medicine FUJIFILM Medical Systems USA, Inc. GE Healthcare Hip Hop Stroke Indiana University School of Medicine Johns Hopkins Medicine Lung Cancer Alliance Massachusetts General Hospital Mayo Clinic Medicalis Corporation Memorial Sloan-Kettering Cancer Center National Alliance for Eye and Vision Research National Patient Advocate Foundation National Stroke Association Nuance Communications, Inc., Nuance Healthcare Division NYU Langone Medical Center Philips Healthcare Saint Lukes Brain and Stroke Institute Siemens Healthcare Society for Pediatric Radiology Society for Women's Health Research TIME MEDICAL Systems, Inc. Toshiba Medical Research Institute University of Arizona College of Medicine University of California, Irvine Medical Center University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Louisville School of Medicine University of Michigan Medical School University of Pennsylvania School of Medicine University of Pittsburgh School of Medicine University of Southern California School of Medicine University of Texas Medical School at Houston University of Utah School of Medicine University of Virginia School of Medicine University of Washington School of Medicine University of Wisconsin-Madison Von Hippel-Lindau Disease Family Alliance Mallinckrodt Institute of Radiology, Washington University Yale University School of Medicine ZERO- the Project to End Prostate Cancer